Real-world of Nintedanib in a Spanish non-IPF progressive pulmonary fibrosis cohort

被引：0
作者：
Vicens Zygmunt, Vanesa [1 ]
Bordas-Martinez, Jaume [1 ]
Munoz-Bolano, Miriam [2 ]
Carmezim-Correia, Joao [3 ]
Belen Llanos-Gonzalez, Ana [4 ]
Domingo-Carnice, Adria [5 ]
Rodriguez-Cumplido, Dolores [5 ]
Bermudo-Peloche, Guadalupe [1 ]
Tebe-Cordomi, Cristian [6 ]
Llop-Rius, Roser [5 ]
Molina-Molina, Maria [7 ]
机构：
[1] Univ Hosp Bellvitge, ILD Unit, Barcelona, Spain
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Bellvitge Biomed Res Inst IDIBELL, Biostatist Unit UBiDi, Barcelona, Spain
[4] Univ Complex Hosp Canarias, ILD Unit, Santa Cruz De Tenerife, Spain
[5] Univ Hosp Bellvitge, Barcelona, Spain
[6] Bellvitge Biomed Res Inst IDIBELL, Biostat Unit UBiDi, Barcelona, Spain
[7] Univ Hosp Bellvitge, ILD Unit, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA408
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Malaysian real-world data to describe progressive pulmonary fibrosis (PPF) in a clinical setting
    Aflah, Syazatul Syakirin Sirol
    Sulaiman, Noraishah
    Lilah, Mohd Syahin Shahira
    Khoo, Ming Yi
    Leow, Wooi Leong
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
    Dixon, Giles
    Hague, Samuel
    Mulholland, Sarah
    Adamali, Huzaifa
    Khin, Aye Myat Noe
    Thould, Hannah
    Connon, Roisin
    Minnis, Paul
    Murtagh, Eoin
    Khan, Fasihul
    Toor, Sameen
    Lawrence, Alexandra
    Naqvi, Marium
    West, Alex
    Coker, Robina K.
    Ward, Katie
    Yazbeck, Leda
    Hart, Simon
    Garfoot, Theresa
    Newman, Kate
    Rivera-Ortega, Pilar
    Stranks, Lachlan
    Beirne, Paul
    Bradley, Jessica
    Rowan, Catherine
    Agnew, Sarah
    Ahmad, Mahin
    Spencer, Lisa G.
    Aigbirior, Joshua
    Fahim, Ahmed
    Wilson, Andrew M.
    Butcher, Elizabeth
    Chong, Sy Giin
    Saini, Gauri
    Zulfikar, Sabrina
    Chua, Felix
    George, Peter M.
    Kokosi, Maria
    Kouranos, Vasileios
    Molyneaux, Philip
    Renzoni, Elisabetta
    Vitri, Benedetta
    Wells, Athol U.
    Nicol, Lisa M.
    Bianchi, Stephen
    Kular, Raman
    Liu, Hua Jian
    John, Alexander
    Barth, Sarah
    Wickremasinghe, Melissa
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [44] Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting
    Kato, Motoyasu
    Sasaki, Shinichi
    Tateyama, Misa
    Arai, Yuta
    Motomura, Hiroaki
    Sumiyoshi, Issei
    Ochi, Yusuke
    Watanabe, Junko
    Ihara, Hiroaki
    Togo, Shinsaku
    Takahashi, Kazuhisa
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 223 - 230
  • [45] Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
    Guenther, Andreas
    Prasse, Antje
    Kreuter, Michael
    Neuser, Petra
    Rabe, Klaus
    Bonella, Francesco
    Bonnet, Reiner
    Grohe, Christian
    Held, Matthias
    Wilkens, Heinrike
    Hammerl, Peter
    Koschel, Dirk
    Blaas, Stefan
    Wirtz, Hubert
    Ficker, Joachim
    Neumeister, Wolfgang
    Schoenfeld, Nicolaus
    Claussen, Martin
    Kneidinger, Nikolaus
    Frankenberger, Marion
    Hummler, Simone
    Kahn, Nicolas
    Tello, Silke
    Freise, Julia
    Welte, Tobias
    Schade-Brittinger, Carmen
    Behr, Juergen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] Tolerability and Overall Mortality in Patients With Non-idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease Treated With Nintedanib: Real-world Evidence From a Single Specialist Centre
    Ortega, P. Rivera
    Stranks, L.
    Newman, K.
    Garfoot, T.
    Morris, H.
    Zakis, K.
    Swale, J.
    Greaves, M.
    Stanel, S.
    Avram, C.
    Blaikley, J.
    Hayton, C.
    Leonard, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [47] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [48] Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain
    Valenzuela, Claudia
    Molina, Maria Molina
    Portal, Jose Antonio Rodriguez
    Ortiz, Romero
    Cano, Esteban
    Nieto, Maria Jesus Rodriguez
    Laporta, Rosalia
    Ancochea, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [49] Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedanib
    Tang, W.
    Menjoge, S.
    Stowasser, S.
    Korell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world
    Nakamura, Masayuki
    Okamoto, Masaki
    Fujimoto, Kiminori
    Ebata, Tomohiro
    Tominaga, Masaki
    Nouno, Takashi
    Zaizen, Yoshiaki
    Kaieda, Shinjiro
    Tsuda, Tohru
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (12)
12345